SARS-CoV-2 sneezing explained
- PMID: 38271509
- DOI: 10.1126/science.ado2398
SARS-CoV-2 sneezing explained
Abstract
Viral protein prods nerve cells, may be treatment target.
Similar articles
-
Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors.Biochem Biophys Res Commun. 2021 Jan 29;538:72-79. doi: 10.1016/j.bbrc.2020.11.083. Epub 2020 Nov 28. Biochem Biophys Res Commun. 2021. PMID: 33276953 Free PMC article.
-
SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species.Emerg Microbes Infect. 2021 Dec;10(1):178-195. doi: 10.1080/22221751.2020.1870414. Emerg Microbes Infect. 2021. PMID: 33372854 Free PMC article.
-
The emerging SARS-CoV-2 papain-like protease: Its relationship with recent coronavirus epidemics.J Med Virol. 2021 Mar;93(3):1581-1588. doi: 10.1002/jmv.26497. Epub 2020 Sep 28. J Med Virol. 2021. PMID: 32902889
-
A Patent Review on SARS Coronavirus Papain-Like Protease (PLpro ) Inhibitors.ChemMedChem. 2023 Aug 15;18(16):e202300216. doi: 10.1002/cmdc.202300216. Epub 2023 Jun 15. ChemMedChem. 2023. PMID: 37248169 Review.
-
Targeting SARS-CoV-2 viral proteases as a therapeutic strategy to treat COVID-19.J Med Virol. 2021 May;93(5):2722-2734. doi: 10.1002/jmv.26814. Epub 2021 Feb 9. J Med Virol. 2021. PMID: 33475167 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous